News | Artificial Intelligence | July 25, 2022

Blackford Announces Partnership with Us2.ai For Advanced Echo Interpretation

New AI tools can produce fully automated echo report in under 2 minutes 

New AI tools can produce fully automated echo report in under 2 minutes

July 25, 2022 — Blackford, the platform for medical imaging applications and AI, and Us2.ai today announced their partnership to bring advanced echocardiography analysis tools to the Blackford Platform. The Blackford Platform enables the seamless selection and integration of AI applications into medical imaging workflows, which supports the complex measurement and reporting needs of clinicians. 

Reducing Time and Improving Access to Diagnosis 

Heart disease remains the number one cause of death around the world.[1] Echocardiography is an affordable, front-line tool used to diagnose and assess heart disease, but the process of acquiring, measuring, and analyzing the images is time-consuming and highly variable. Groundbreaking machine learning technology from Us2.ai can reduce the time to process and interpret echocardiograms from 30 minutes to under 2 minutes, with zero variability and with accuracy interchangeable with expert clinicians. 

“With cardiologists under incredible time pressure and an acute, worldwide shortage of sonographers, we believe that harnessing the power of AI can enable more efficient and effective cardiac care,” said Ben Panter, Blackford CEO. “We’re excited to partner with Us2.ai and facilitate the availability of fast, reproducible echo analysis to global healthcare professionals via our whole-of-market AI platform.” 

Fully Automated Cardiac Measurement and Reporting 

After the echocardiographer acquires a study, the FDA and CE cleared Us2 software automatically analyzes all the heart chambers, using both 2D and Doppler views to create a full echo report with findings for heart structure and function in under 2 minutes. The fully automated cardiac measurements included in the software cover most standard measurements for adult transthoracic echocardiography recommended by the American and British Societies of Echocardiography and the European Association of Cardiovascular Imaging. 

“This partnership accelerates our mission to automate the fight against heart disease,” said James Hare, CEO and co-founder of Us2.ai. “We are proud to partner with Blackford and take advantage of our growing list of global regulatory clearances to ensure cardiologists are armed with all the facts to detect heart issues early and with ease.” 

For more information: www.blackfordanalysis.com 


Additional Content

News | Cardiovascular Business

Oct. 5, 2026 – Endologix Holdings, LLC has announced Rhevera Medical as its new corporate brand. The new identity ...

Home October 05, 2026
Home
News | Cardiovascular Business

Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...

Home August 10, 2026
Home
News | Cardiovascular Business

July 30, 2026 — João Seabra, head of Siemens Healthineers Enterprise Services, has been appointed president and Head of ...

Home August 06, 2026
Home
News | Cardiovascular Business

April 9, 2026 — Cardiovascular demand continues to rise across the United States, placing increasing pressure on ...

Home April 10, 2026
Home
News | Cardiovascular Business

March 13, 2026 — According to a new research study published by Vyansa Intelligence, the Cardiovascular Devices Market ...

Home March 23, 2026
Home
Subscribe Now